News Release--> BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale, adding potential new revenue stream from products and CDMO opportunities. Read full news release: https://lnkd.in/gXfj2-BS
BioHarvest Sciences
Biotechnology Research
Vancouver, British Columbia 2,707 followers
We leverage our Botanical Synthesis technology to produce plant-based compounds that improve human wellness
About us
BioHarvest Sciences Inc. (Nasdaq: BHST) is a public biotech company that has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial compounds in fruit & plants, at an industrial scale, without the need to grow the plant itself. BioHarvest has invested 17 years and >$100M to develop our Botanical Synthesis Technology, which produces unique and patentable botanical compositions which contain a “target optimized” combination of the phyto-medicinal compounds (with high solubility and bio-availability) found in the original plant. No other company has developed a commercially viable plant cell culture platform at the industrial scale of BioHarvest. BioHarvest is focused on leveraging this platform technology across the following business units: 1. Biologics+ CDMO Services: BioHarvest is leveraging its Botanical Synthesis technology to allow global pharmaceutical, nutrition, cosmetics, and nutraceutical partners to develop proprietary compounds with unmatched predictability and consistency, manufactured at industrial scale under exclusive partnerships. 2. Direct to Consumer Business Anchored in Science: BioHarvest has built its own direct to consumer business of propriety botanical compositions. The first product, VINIA® was launched into the US in 2021 and has now exceeded 60,000 daily users (>$50M USD Revenue since 2021 launch). VINIA® contains multiple polyphenols, including Piceid Resveratrol, with an amount in each daily 400mg capsule that is equivalent to 1,000 grapes, resulting in a powerful nutraceutical that has been clinically proven (in a published double-blind placebo-controlled study), to significantly increase dilation of arteries. This increased dilation of arteries improves blood flow and the delivery of oxygen and nutrients to the body, tissue & organs.
- Website
-
https://www.bioharvest.com
External link for BioHarvest Sciences
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Vancouver, British Columbia
- Type
- Public Company
- Founded
- 2018
Locations
-
Primary
Get directions
625 Howe St.
Suite 1140
Vancouver, British Columbia V6C2T6, CA
Employees at BioHarvest Sciences
Updates
-
The September 10 Investor Webinar recording is now available: https://lnkd.in/gcXZyuWJ The recording includes Ilan Sobel's slide presentation plus full Q+A session featuring analysts and Chairman Zaki Rakib.
-
-
Join the Sept. 10 BioHarvest Investor Webinar. CEO Ilan Sobel will discuss new capabilities and growth initiatives for 2H 2025. Time: 1pm EST September 10 Registration link: https://lnkd.in/gWwjH24Q The event recording will be available to all registrants via the webcast link.
-
-
BioHarvest Webinar 1 pm EST September 10--> CEO Ilan Sobel will host an investor webinar to provide a corporate update on new capability-building initiatives, the Company’s ‘Big Bets’ for 2H 2025, and will conclude with a question-and-answer session from dial-in participants. The webcast is open to all interested media and investors. Date: Wednesday, September 10, 2025 Time: 1:00 p.m. Eastern time Webcast link: https://lnkd.in/dwNXravJ View News Release:https://lnkd.in/gXfj2-BS
-
The BHST Q2 Earnings call highlighted three major new initiatives for 2H 2025: · Hydration product targeting launch in late September · "VINIA Health Pros" professional affiliate program launch · New "Discovery Phase" added for Biologics+ CDMO customers View recorded Q2 2025 Earnings webcast here: https://lnkd.in/gZdAekbY View Q2 Earnings News Release: https://lnkd.in/gp7VQbUX #botanicalsynthesis #CDMO #sustainableinvesting #biotech
-
-
Live Presentation 11 AM ET Aug. 12, 2025--> Join CEO Ilan Sobel via webcast as he presents at the Canaccord Genuity 45th Annual Growth Conference in Boston. All investors are invited to watch this live presentation: https://lnkd.in/gjPxjMew The presentation recording will be available at this same link after the event.
-
-
The webcast recording of today's Q2 2025 Earnings call is now available: http://bit.ly/4lo6buA The recording Includes presentation slides and full analyst Q+A session.
-
-
News Release--> BioHarvest Sciences Reports Second Quarter 2025 Financial Results. Company to host Earnings call today, August 11 at 8am ET. Read Full Release: https://lnkd.in/gXfj2-BS
-
-
News Release--> BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time. All investors are welcome to join the live webcast, or to watch the recording at their convenience. Click for webcast link: http://bit.ly/4fkf5I9 View News Release: http://bit.ly/45iIKwF
-
-
Educating health conscious consumers--> Dr. Eddie Maristany, Functional Medicine Physician, explains how age impacts microcirculation. VINIA has been clinically proven to dilate blood vessels, which improves blood flow. #bloodflow #piciedresveratrol #longevity